BerandaE2XA34 • BVMF
add
Exact Sciences Corp
Tutup sebelumnya
R$29,28
Rentang tahun
R$23,36 - R$42,10
Kapitalisasi pasar
10,30 M USD
Volume Rata-Rata
55,00
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 706,78 jt | 10,86% |
Biaya operasional | 582,02 jt | 7,25% |
Laba bersih | -101,22 jt | 8,18% |
Margin laba bersih | -14,32 | 17,18% |
Penghasilan per saham | -0,36 | 33,45% |
EBITDA | -27,41 jt | 35,40% |
Tarif pajak efektif | -0,22% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 786,18 jt | 20,56% |
Total aset | 5,71 M | -10,43% |
Total liabilitas | 3,31 M | 2,17% |
Total ekuitas | 2,40 M | — |
Saham yang beredar | 188,64 jt | — |
Harga terhadap nilai buku | 2,30 | — |
Tingkat pengembalian aset | -3,50% | — |
Tingkat pengembalian modal | -4,03% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -101,22 jt | 8,18% |
Kas dari operasi | 30,81 jt | 137,43% |
Kas dari investasi | -34,44 jt | 79,91% |
Kas dari pembiayaan | -256,17 jt | -8.433,34% |
Perubahan kas bersih | -259,51 jt | -0,63% |
Arus kas bebas | -11,34 jt | 90,41% |
Tentang
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer. Since then Exact Sciences has grown its product portfolio to encompass other screening and precision oncological tests for other types of cancer. Wikipedia
CEO
Didirikan
1 Jan 1995
Kantor pusat
Situs
Karyawan
6.950
